NL6607589A - - Google Patents

Info

Publication number
NL6607589A
NL6607589A NL6607589A NL6607589A NL6607589A NL 6607589 A NL6607589 A NL 6607589A NL 6607589 A NL6607589 A NL 6607589A NL 6607589 A NL6607589 A NL 6607589A NL 6607589 A NL6607589 A NL 6607589A
Authority
NL
Netherlands
Application number
NL6607589A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6607589A publication Critical patent/NL6607589A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/14Topical contraceptives and spermacides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL6607589A 1965-06-01 1966-06-01 NL6607589A (US08124317-20120228-C00038.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US460505A US3370071A (en) 1965-06-01 1965-06-01 3-keto-13beta-alkyl-17beta-acetyl-gona-4, 9-dienes and process

Publications (1)

Publication Number Publication Date
NL6607589A true NL6607589A (US08124317-20120228-C00038.png) 1966-12-02

Family

ID=23828981

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6607589A NL6607589A (US08124317-20120228-C00038.png) 1965-06-01 1966-06-01

Country Status (6)

Country Link
US (1) US3370071A (US08124317-20120228-C00038.png)
BR (1) BR6680056D0 (US08124317-20120228-C00038.png)
CH (1) CH467254A (US08124317-20120228-C00038.png)
DE (1) DE1593026A1 (US08124317-20120228-C00038.png)
GB (1) GB1138694A (US08124317-20120228-C00038.png)
NL (1) NL6607589A (US08124317-20120228-C00038.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002490A1 (en) * 1987-09-16 1989-03-23 Eltech Systems Corporation Composite cell bottom for aluminum electrowinning

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
US3243433A (en) * 1961-08-04 1966-03-29 Squibb & Sons Inc Steroids of the 19-norpregnane series
US3102125A (en) * 1961-09-26 1963-08-27 Syntex Corp delta5(10)-pregnene compounds
US3300518A (en) * 1961-10-04 1967-01-24 Merck & Co Inc 17alpha-trifluorovinyl androstenes
US3189528A (en) * 1963-07-25 1965-06-15 American Home Prod Resolution of racemic delta4-3-keto-13beta-alkyl steroids by using corynebacterium siplex
NL125068C (US08124317-20120228-C00038.png) * 1964-06-01

Also Published As

Publication number Publication date
GB1138694A (en) 1969-01-01
DE1593026A1 (de) 1970-10-22
BR6680056D0 (pt) 1973-12-26
US3370071A (en) 1968-02-20
CH467254A (de) 1969-01-15

Similar Documents

Publication Publication Date Title
BE675324A (US08124317-20120228-C00038.png)
JPS4425962Y1 (US08124317-20120228-C00038.png)
JPS4311965Y1 (US08124317-20120228-C00038.png)
DE1559133A1 (US08124317-20120228-C00038.png)
BE674895A (US08124317-20120228-C00038.png)
BE663625A (US08124317-20120228-C00038.png)
BE664290A (US08124317-20120228-C00038.png)
BE664771A (US08124317-20120228-C00038.png)
BE665422A (US08124317-20120228-C00038.png)
BE667990A (US08124317-20120228-C00038.png)
BE668441A (US08124317-20120228-C00038.png)
BE668816A (US08124317-20120228-C00038.png)
BE670037A (US08124317-20120228-C00038.png)
BE671093A (US08124317-20120228-C00038.png)
BE671542A (US08124317-20120228-C00038.png)
BE672210A (US08124317-20120228-C00038.png)
BE672486A (US08124317-20120228-C00038.png)
BE673130A (US08124317-20120228-C00038.png)
BE673314A (US08124317-20120228-C00038.png)
BE674079A (US08124317-20120228-C00038.png)
BE674169A (US08124317-20120228-C00038.png)
BE674502A (US08124317-20120228-C00038.png)
BE674521A (US08124317-20120228-C00038.png)
BE674579A (US08124317-20120228-C00038.png)
BE674621A (US08124317-20120228-C00038.png)